Use this resource in conjunction with your real-world training

In this 360° experience, watch an A to E assessment on a 41-year-old patient named Adam.
Please note that these A to E assessments are intended for reflection and discussion. They are not perfect patient assessments, and investigation and management of these patients may change according to your local guidelines.
41-year-old male: Adam
PC: Chest pain
HPC: Sudden onset of central non-pleuritic chest pain. Started 2 hours ago while at work. Radiates to left arm and associated with some SOB. No palpitations. No N&V. No history of previous chest pains.
PMH: Hypertension
DH: Amlodipine. NKDA
FH: Father died of MI – age 46 years
SH: Builder / smoker – 1 pack/day for 23 years. Occasional Cannabis. Lives with wife
Acute coronary syndrome (ACS) refers to a spectrum of conditions caused by sudden, reduced blood flow to the heart, most commonly due to rupture or erosion of an atherosclerotic plaque with subsequent thrombus formation. It encompasses unstable angina, non–ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). Clinically, patients often present with chest pain or pressure, which may radiate to the arm, neck, or jaw, along with diaphoresis, dyspnea, nausea, or a sense of impending doom. Prompt evaluation includes ECG monitoring to detect ischemic changes and measurement of cardiac biomarkers—particularly high-sensitivity troponins—to identify myocardial injury.
Management begins with rapid stabilisation: oxygen if hypoxic, analgesia, and antiplatelet therapy. Aspirin is given immediately, followed by a P2Y12 inhibitor and anticoagulation. Beta-blockers, nitrates, and statins are initiated based on hemodynamic status and contraindications. STEMI requires urgent reperfusion, ideally through primary percutaneous coronary intervention (PCI), or fibrinolysis when PCI is unavailable. NSTEMI and unstable angina are managed with risk stratification tools to guide timing of invasive evaluation; high-risk patients typically undergo early angiography.
Long-term management focuses on secondary prevention—high-intensity statins, dual antiplatelet therapy, lifestyle modification, blood pressure and diabetes control—to reduce recurrent events and improve survival.
